In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex 
A propylene glycol-free intravenous formulation containing the hydrochloride salt of the nitrogen mustard phenylalanine derivative melphalan complexed with polyanionic sulfobutyl ether beta-cyclodextrin (SBE-CD) with potential antineoplastic activity. Upon administration, melphalan is converted into highly reactive ethylenimmonium intermediates that induce covalent guanine N7-N7 intra- and inter-crosslinks and alkylation of adenine N3 of DNA; RNA and proteins may also be alkylated. Subsequently, RNA transcription and protein synthesis are inhibited, resulting in cell growth arrest. The addition of sulfobutyl ether beta-cyclodextrin to the formulation improves the solubility, stability and ease of use of melphalan; cyclodextrins are cyclic dextrins derived from starch. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
US brand name:Captisol-enabled Melphalan IV